MS
55
-4
EIX
40
-5
OKE
46
-7
DOV
53
-4
UAL
28
-16
PCG
53
-5
VIX
77
9
APH
59
-3
NTAP
39
-3
PM
62
-4
APA
25
-6
PFE
14
-2
FLS
49
-4
L
43
-4
WMT
62
-5
XYL
25
-6
AEE
69
-10
AVY
48
-6
XEL
53
-9
BRK.B
33
-5
MS
55
-4
EIX
40
-5
OKE
46
-7
DOV
53
-4
UAL
28
-16
PCG
53
-5
VIX
77
9
APH
59
-3
NTAP
39
-3
PM
62
-4
APA
25
-6
PFE
14
-2
FLS
49
-4
L
43
-4
WMT
62
-5
XYL
25
-6
AEE
69
-10
AVY
48
-6
XEL
53
-9
BRK.B
33
-5
Financhill
Back

PROCEPT BioRobotics 10K Form

Sell
40

PRCT
PROCEPT BioRobotics

Last Price:
$52.68
Seasonality Move:
8.32%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PRCT News And Ratings

See the #1 stock for the next 7 days that we like better than PRCT

PRCT Financial Statistics

Sales & Book Value

Annual Sales: $224.5M
Cash Flow: $-33.6M
Price / Cash Flow: 0
Annual Sales: $7.35
Price / Book: 7.28

Profitability

EPS (TTM): -1.76000
Net Income (TTM): $-91.4M
Gross Margin: $137.1M
Return on Equity: -31.74%
Return on Assets: -22.08%

PROCEPT BioRobotics Earnings Forecast

Key PROCEPT BioRobotics Financial Ratios

  • The Gross Profit Margin over the past 6 years for PRCT is 61.07%.
  • The Selling, General & Administrative Expenses for PRCT have been equal to 76.35% of Gross Profit Margin.
  • The Research & Development expenses have been 27.75% of Revenue.
  • The Net Earning history of PRCT is -40.72% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

PROCEPT BioRobotics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: PRCT
Website: procept-biorobotics.com

Debt

Debt-to-Equity Ratio: 0.13
Current Ratio: 9.07
Quick Ratio: 7.85

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PRCT Technical Analysis vs Fundamental Analysis

Sell
40
PROCEPT BioRobotics (PRCT) is a Sell

Is PROCEPT BioRobotics a Buy or a Sell?